Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $97 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $372 | In Stock | |
25 mg | $629 | In Stock | |
50 mg | $896 | In Stock | |
100 mg | $1,220 | In Stock | |
1 mL x 10 mM (in DMSO) | $272 | In Stock |
Description | SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway. |
In vitro | SIRT7 inhibitor 97491 (1-10 μM) effectively reduces the proliferation of human uterine sarcoma MES-SA cells without exhibiting cytotoxic effects on HEK293 human embryonic kidney cells[1]. Specifically, when applied at concentrations of 1, 5, and 10 μM for 72 hours, it resulted in a greater than 50% decrease in proliferation of MES-SA cells at the 5 and 10 μM concentrations. Conversely, the same concentrations did not significantly affect the viability of HEK293 cells after 24 hours of exposure, indicating selective action. |
In vivo | The SIRT7 inhibitor 97491 (2 mg/kg; intraperitoneally injected; for 3 weeks, except on weekends) effectively suppresses tumor growth in xenograft mice[1]. Utilizing Balb/c nude mice (18-20 g; 6-8 weeks old) implanted with MES-SA cells[1], the dosage administered was 2 mg/kg via intraperitoneal injection over a three-week period, excluding weekends. The outcome was a significant inhibition of cancer growth in vivo. |
Molecular Weight | 285.73 |
Formula | C15H12ClN3O |
Cas No. | 1807758-81-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 500 mg/mL (1749.90 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.